An ionic liquid nanoparticles for dermal targeted delivery and effective anti-wrinkle treatment
Aging is a natural process that cannot be stopped but retarded. Hydroxypinacolone retinoate (HPR) is a potent anti-wrinkle agent, but with severe irritancy, low stability, and poor water solubility, making it hard to apply in cosmetics. Ionic liquid (IL), as a solvent, displayed improved transdermal efficiency. The role of nano-encapsulation technology in addressing the disadvantages of efficacy application is significant. Using a combination of ionic liquids and nano-encapsulation technology to obtain HPR-encapsulated ionic liquid nanoparticles (HPR IL-NPs) is an innovative formulation used as a serum, emulsion, and cream in cosmetics for effective anti-wrinkle. HPR IL-NPs were prepared using matrine coconut oil ionic liquid as a surfactant and permeation enhancer combined with high-pressure homogenization. The average particle size in the obtained HPR IL-NPs was 92.8 nm. Applying the HPR IL-NPs increased the content of active substances in the skin by 3.6-fold compared to a traditional HPR-loaded cream. The chick chorioallantois membrane assay showed an RC50 > 100%, and repeated skin-irritation tests resulted in a mean value of 0.00 points per animal per day. The HPR IL-NPs showed continuous release for 24 hours in vitro in the continuous release test. At the same time, the HPR IL-NPs significantly reduced irritation induced by HPR alone. The number and area of facial wrinkles decreased by 25.09% and 23.65%, respectively, after one week of application of liquid cream on volunteers. IL NPs can significantly improve transdermal absorption efficiency, reduce irritation, and demonstrate high anti-wrinkle efficiency. Supramolecular liquid cream is a promising product in cosmetics for skin care.
Authors
- Jiaheng Zhang (ORCID: https://orcid.org/0000-0002-2377-9796)
- Chengyu Wu (ORCID: https://orcid.org/0000-0003-1547-3516)
- De Bai
- Bo Yang (ORCID: https://orcid.org/0000-0001-8090-4939)
- Jingyao Gan (ORCID: https://orcid.org/0000-0001-6404-4764)
- Jichuan Zhang (ORCID: https://orcid.org/0000-0002-8584-5891)
- Zhenyuan Wang
- Huixian Xu (ORCID: https://orcid.org/0009-0009-7017-3621)
- Qiaomei Huang
Institutions
- Harbin Institute of Technology (CN)
- University of Michigan (US)
- Shenzhen Planck Innovation (China) (CN)
- BioSurfaces (United States) (US)
- Shenzhen Technology University (CN)
Publication Details
- Journal
- Journal of Dermatologic Science and Cosmetic Technology
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1016/j.jdsct.2024.100046
- Citations
- 1
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.21
Funders
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China